Scissortail Wealth Management LLC Makes New $1.63 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Scissortail Wealth Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,221 shares of the healthcare conglomerate's stock, valued at approximately $1,625,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. Robbins Farley bought a new position in shares of UnitedHealth Group during the third quarter valued at about $25,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC lifted its holdings in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock worth $33,000 after buying an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA lifted its holdings in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate's stock worth $35,000 after buying an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating for the company in a report on Monday, April 8th. Oppenheimer restated an "outperform" rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Barclays assumed coverage on shares of UnitedHealth Group in a research note on Wednesday, March 6th. They set an "overweight" rating and a $551.00 target price for the company. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an "overweight" rating for the company in a research note on Friday, April 5th. Finally, HSBC raised shares of UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Three analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average price target of $573.80.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $23.51 during trading hours on Tuesday, reaching $469.14. The company had a trading volume of 11,815,185 shares, compared to its average volume of 4,407,902. The firm's 50 day moving average price is $491.15 and its 200-day moving average price is $515.88. The firm has a market cap of $432.51 billion, a price-to-earnings ratio of 19.66, a PEG ratio of 1.20 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.54 by $0.37. The business had revenue of $99.80 billion for the quarter, compared to analysts' expectations of $99.23 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company's revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.26 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's dividend payout ratio (DPR) is 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.